“…Previous studies indicated that Cas9 and Cas12a rely on PAM recognition to initiate unwinding of the protospacer segment in the dsDNA target, thus facilitating subsequent guide RNA invasion and R-loop formation 49,50 . Recently, researchers revealed that DNA topology regulates the interaction between AtCas9 and target DNA, enabling near-PAMless cleavage 51 . That may provide a possible explanation for LbuCas13a targeting dsDNA.…”
Traditionally perceived as an RNA-specific nuclease, Cas13a has garnered extensive utilization in RNA detection. This paradigm is challenged by our discovery of LbuCas13a's ability to directly target DNA without the restrictions of (Protospacer Flanking Sequence) FPS and (Protospacer Adjacent Motif) PAM sequences, coupled with robust trans-cleavage activity, a breakthrough in CRISPR-based diagnostics. Contrary to conventional understanding, LbuCas13a does not degrade DNA targets, thereby enabling retesting. Remarkably, our study reveals a striking enhancement in LbuCas13a's single nucleotide specificity against DNA (a 98-fold increase compared to RNA). This heightened specificity is attributed to the lower affinity of crRNA towards DNA, raising the crRNA-DNA binding energy barrier. Leveraging this discovery, we introduce a pioneering molecular diagnostic platform: Advanced LbuCas13a-Strong-Specificity DNA Universal Rapid Enhanced Detection (ASSURED), which achieves high-resolution genotyping, exemplified by the accurate discrimination of the CYP2C19*3 gene variant. ASSURED exhibits exceptional sensitivity, capable of detecting DNA concentrations as minute as 0.3 aM (0.18 cps/µL). ASSURED represents a significant advancement in real-time nucleic acid detection, with its unparalleled specificity and sensitivity, making it an ideal tool for pathogen identification and mutation analysis in clinical diagnostics.
“…Previous studies indicated that Cas9 and Cas12a rely on PAM recognition to initiate unwinding of the protospacer segment in the dsDNA target, thus facilitating subsequent guide RNA invasion and R-loop formation 49,50 . Recently, researchers revealed that DNA topology regulates the interaction between AtCas9 and target DNA, enabling near-PAMless cleavage 51 . That may provide a possible explanation for LbuCas13a targeting dsDNA.…”
Traditionally perceived as an RNA-specific nuclease, Cas13a has garnered extensive utilization in RNA detection. This paradigm is challenged by our discovery of LbuCas13a's ability to directly target DNA without the restrictions of (Protospacer Flanking Sequence) FPS and (Protospacer Adjacent Motif) PAM sequences, coupled with robust trans-cleavage activity, a breakthrough in CRISPR-based diagnostics. Contrary to conventional understanding, LbuCas13a does not degrade DNA targets, thereby enabling retesting. Remarkably, our study reveals a striking enhancement in LbuCas13a's single nucleotide specificity against DNA (a 98-fold increase compared to RNA). This heightened specificity is attributed to the lower affinity of crRNA towards DNA, raising the crRNA-DNA binding energy barrier. Leveraging this discovery, we introduce a pioneering molecular diagnostic platform: Advanced LbuCas13a-Strong-Specificity DNA Universal Rapid Enhanced Detection (ASSURED), which achieves high-resolution genotyping, exemplified by the accurate discrimination of the CYP2C19*3 gene variant. ASSURED exhibits exceptional sensitivity, capable of detecting DNA concentrations as minute as 0.3 aM (0.18 cps/µL). ASSURED represents a significant advancement in real-time nucleic acid detection, with its unparalleled specificity and sensitivity, making it an ideal tool for pathogen identification and mutation analysis in clinical diagnostics.
“…Another high-fidelity Cas9 identified from thermophile Alicyclobacillus tengchongensis (AtCas9) had a relaxed N 4 CNNN and N 4 RNNA (R = A or G) PAM preference. Notably, its PAM interaction could be robustly regulated by DNA topology and was able to bind targets with mutated PAMs . With this unique mechanism, AtCas9 exhibited near-PAMless base editing of supercoiled plasmid in E.…”
Section: Optimization Strategies Based On Core Component
Engineering ...mentioning
confidence: 99%
“…Notably, its PAM interaction could be robustly regulated by DNA topology and was able to bind targets with mutated PAMs. 14 With this unique mechanism, AtCas9 exhibited near-PAMless base editing of supercoiled plasmid in E. coli, which symbolized it as a plausible plasmid BE candidate.…”
Section: Expanding Pam Compatibility By Harnessing Casmentioning
Base editors (BE) based on CRISPR systems are practical gene-editing tools which continue to drive frontier advances of life sciences. BEs are able to efficiently induce point mutations at target sites without double-stranded DNA cleavage. Hence, they are widely employed in the fields of microbial genome engineering. As applications of BEs continue to expand, the demands for base-editing efficiency, fidelity, and versatility are also on the rise. In recent years, a series of optimization strategies for BEs have been developed. By engineering the core components of BEs or adopting different assembly methods, the performance of BEs has been well optimized. Moreover, series of newly established BEs have significantly expanded the base-editing toolsets. In this Review, we will summarize the current efforts for BE optimization, introduce several novel BEs with versatility, and look forward to the broadened applications for industrial microorganisms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.